Catalyst Pharmaceuticals
CPRX
#3601
Rank
A$5.73 B
Marketcap
A$46.86
Share price
0.00%
Change (1 day)
49.96%
Change (1 year)

EPS for Catalyst Pharmaceuticals (CPRX)

EPS in 2026 (TTM): A$2.70

According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$2.69. In 2025 the company made an earnings per share (EPS) of A$2.62 an increase over its 2024 EPS that were of A$2.07.

EPS history for Catalyst Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.702.99%
2025A$2.6226.62%
2024A$2.07
2022A$1.19110.53%
2021A$0.57-47.22%
2020A$1.07132.26%
2019A$0.46-191.18%
2018A-$0.5154.55%
2017A-$0.33-4.35%
2016A-$0.34-8%
2015A-$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.94 269.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.06-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.02 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A-$3.91-245.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A-$74.87-2,879.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.13-104.97%๐Ÿ‡บ๐Ÿ‡ธ USA